Organon & Co. (OGN) Financials
OGN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 12.1 billion | 12.1 billion |
| 2023-09-30 | 11.0 billion | 11.6 billion |
| 2023-06-30 | 11.0 billion | 11.5 billion |
| 2023-03-31 | 10.8 billion | 11.5 billion |
OGN Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 316.0 million | 27.0 million |
| 2023-09-30 | 206.0 million | 27.0 million |
| 2023-06-30 | -44.0 million | 25.0 million |
| 2023-03-31 | 60.0 million | 22.0 million |
OGN Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 546.0 million |
| 2023-09-30 | 58.0 million |
| 2023-06-30 | 242.0 million |
| 2023-03-31 | 177.0 million |
OGN Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 693.0 million | - | - |
| 2023-09-30 | 414.0 million | 8.6 billion | - |
| 2023-06-30 | 326.0 million | 8.7 billion | - |
| 2023-03-31 | 459.0 million | 8.7 billion | - |
OGN Shares Outstanding
OGN Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 81.0 million | 134.0 million | 469.0 million | - |
| 2023-09-30 | 55.0 million | 137.0 million | 497.0 million | - |
| 2023-06-30 | 71.0 million | 128.0 million | 451.0 million | - |
| 2023-03-31 | 54.0 million | 129.0 million | 435.0 million | - |
OGN Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 1.6 billion | 683.0 million |
| 2023-09-30 | 1.5 billion | 612.0 million |
| 2023-06-30 | 1.6 billion | 640.0 million |
| 2023-03-31 | 1.5 billion | 580.0 million |
OGN
Price: $18.55
Dividend Yield: 0.06%
Forward Dividend Yield: 6.04%
Payout Ratio: 49.12%
Dividend Per Share: 1.12 USD
Earnings Per Share: 3.99 USD
P/E Ratio: 7.18
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 1.6 million
Market Capitalization: 4.6 billion
Average Dividend Frequency: 4
Years Paying Dividends: 4